Reckamp K - Search Results

1

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.

Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, Huang M, Batra RK, Dubinett SM. Sharma S, et al. Among authors: reckamp k. Cancer Res. 2005 Jun 15;65(12):5211-20. doi: 10.1158/0008-5472.CAN-05-0141. Cancer Res. 2005. PMID: 15958566

2

PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells.

Baratelli F, Krysan K, Heuzé-Vourc'h N, Zhu L, Escuadro B, Sharma S, Reckamp K, Dohadwala M, Dubinett SM. Baratelli F, et al. Among authors: reckamp k. J Leukoc Biol. 2005 Aug;78(2):555-64. doi: 10.1189/jlb.1004569. Epub 2005 May 20. J Leukoc Biol. 2005. PMID: 15908458

3

Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses.

Sharma S, Zhu L, Yang SC, Zhang L, Lin J, Hillinger S, Gardner B, Reckamp K, Strieter RM, Huang M, Batra RK, Dubinett SM. Sharma S, et al. Among authors: reckamp k. J Immunol. 2005 Jul 15;175(2):813-9. doi: 10.4049/jimmunol.175.2.813. J Immunol. 2005. PMID: 16002678

4

Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.

Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM. Krysan K, et al. Among authors: reckamp kl. Cancer Res. 2005 Jul 15;65(14):6275-81. doi: 10.1158/0008-5472.CAN-05-0216. Cancer Res. 2005. PMID: 16024629

5

Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.

Baratelli F, Lin Y, Zhu L, Yang SC, Heuzé-Vourc'h N, Zeng G, Reckamp K, Dohadwala M, Sharma S, Dubinett SM. Baratelli F, et al. Among authors: reckamp k. J Immunol. 2005 Aug 1;175(3):1483-90. doi: 10.4049/jimmunol.175.3.1483. J Immunol. 2005. PMID: 16034085

6

Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.

Mao JT, Cui X, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter R, Gardner B, Dubinett SM. Mao JT, et al. Among authors: reckamp k. Clin Lung Cancer. 2005 Jul;7(1):30-9. doi: 10.3816/CLC.2005.n.019. Clin Lung Cancer. 2005. PMID: 16098242 Review.

7

Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.

Yang SC, Batra RK, Hillinger S, Reckamp KL, Strieter RM, Dubinett SM, Sharma S. Yang SC, et al. Among authors: reckamp kl. Cancer Res. 2006 Mar 15;66(6):3205-13. doi: 10.1158/0008-5472.CAN-05-3619. Cancer Res. 2006. PMID: 16540672

8

The potential and rationale for COX-2 inhibitors in lung cancer.

Krysan K, Reckamp KL, Sharma S, Dubinett SM. Krysan K, et al. Among authors: reckamp kl. Anticancer Agents Med Chem. 2006 May;6(3):209-20. doi: 10.2174/187152006776930882. Anticancer Agents Med Chem. 2006. PMID: 16712449 Review.

9

A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.

Reckamp KL, Krysan K, Morrow JD, Milne GL, Newman RA, Tucker C, Elashoff RM, Dubinett SM, Figlin RA. Reckamp KL, et al. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3381-8. doi: 10.1158/1078-0432.CCR-06-0112. Clin Cancer Res. 2006. PMID: 16740761 Clinical Trial.

10

Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.

Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM. Pan J, et al. Among authors: reckamp k. Mol Cancer. 2006 Nov 3;5:56. doi: 10.1186/1476-4598-5-56. Mol Cancer. 2006. PMID: 17083723 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters